Survival Outcomes of Patients with Follicular Lymphoma after Relapse or Progression: A Single-Center Real-World Data Analysis.
Yong-Pyo LeeMin-Sang LeeSang Eun YoonJunhun ChoYeong Hak BangJoon Ho ShimWon Seog KimSeok Jin KimPublished in: Journal of oncology (2022)
Relapsed or refractory FL patients showed various clinical courses and treatment outcomes according to relapse or progression. Consolidation treatment with ASCT and active participation to clinical trials might prolong survival duration, especially in POD24 cases.
Keyphrases
- data analysis
- clinical trial
- end stage renal disease
- free survival
- ejection fraction
- newly diagnosed
- chronic kidney disease
- acute lymphoblastic leukemia
- acute myeloid leukemia
- peritoneal dialysis
- prognostic factors
- diffuse large b cell lymphoma
- randomized controlled trial
- open label
- patient reported
- replacement therapy